Evidence map›Paper›PMID 32309139›Full record

ArticleJournal of orthopaedic translation2020

Development of bone seeker-functionalised microspheres as a targeted local antibiotic delivery system for bone infections.

Stijn G Rotman, Keith Thompson, Dirk W Grijpma, Robert G Richards, Thomas F Moriarty, David Eglin, Olivier Guillaume

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic translation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Diflunisal-loaded poly(propylene sulfide) nanoparticles decrease S. aureus-mediated bone destruction during osteomyelitis.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Stijn G RotmanMusculoskeletal Regeneration Program, AO Research Institute Davos, Davos, Switzerland.
Keith ThompsonMusculoskeletal Regeneration Program, AO Research Institute Davos, Davos, Switzerland.
Dirk W GrijpmaDepartment of Biomaterials Science and Technology, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Robert G RichardsMusculoskeletal Regeneration Program, AO Research Institute Davos, Davos, Switzerland.
Thomas F MoriartyMusculoskeletal Regeneration Program, AO Research Institute Davos, Davos, Switzerland.
David EglinMusculoskeletal Regeneration Program, AO Research Institute Davos, Davos, Switzerland.
Olivier GuillaumeMusculoskeletal Regeneration Program, AO Research Institute Davos, Davos, Switzerland.
AO Foundation · CHUniversity of Twente · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBone infections are challenging to treat because of limited capability of systemic antibiotics to accumulate at the bone site. To enhance therapeutic action, systemic treatments are commonly combined with local antibiotic-loaded materials. Nevertheless, available drug carriers have undesirable properties, including inappropriate antibiotic release profiles and nonbiodegradability. To alleviate such limitations, we aim to develop a drug delivery system (DDS) for local administration that can interact strongly with bone mineral, releasing antibiotics at the infected bone site.

methodsBiodegradable polyesters (poly (ε-caprolactone) or poly (D,l-lactic acid)) were selected to fabricate antibiotic-loaded microspheres by oil in water emulsion. Antibiotic release and antimicrobial effects on

results

conclusionWe report the development and characterisation of a DDS which can release antibiotics in a sustained manner. Surface-grafted alendronate groups enhanced bone affinity of the microsphere construct, resulting in a bone targeting DDS. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: The DDS presented can be loaded with hydrophobic antibiotics, representing a potential, versatile and biodegradable candidate to locally treat bone infection.

Indexed as

AlendronateBone infectionBone targetingDrug deliveryMicroparticleOsteomyelitis

Identifiers

PMID32309139
PMCPMC7152806
OpenAlexW2971355456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.